Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Novavax (NVAX) has caught the attention of investors this month, as its stock climbed over 26% in the past 30 days. The company’s performance draws curiosity about what might be fueling the move, ...

In the latest close session, Novavax (NVAX) was down 4.02% at $9.08. This move lagged the S&P 500's daily gain of 0.37%. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq gained 0.71%.

Shares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) have been given a consensus rating of “Hold” by the eight research firms that are currently covering the firm, MarketBeat.com reports. Three ...

Based on these projections, Novavax’s estimated intrinsic value per share comes out to $2.49. With the stock recently closing at $7.98, this implies it is trading at a 221.1% premium to its calculated ...

Stream Connecticut News for free, 24/7, wherever you are. Novavax could pay up to $475 million to the organization, but the total amount may be less if Gavi decides to order more shots from the ...

Shares of Novavax Inc. NVAX slid 2.15% to $7.73 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.45% to 21,798.70 ...

Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding ...

Shares of Novavax Inc. NVAX slipped 2.25% to $8.67 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.95% to ...